Skip to content

Soft Lens Study: Biomedics 1 Day Extra Sphere and Clariti 1 Day Sphere

Soft Lens Study: Biomedics 1 Day Extra Sphere and Clariti 1 Day Sphere

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06817785
Enrollment
45
Registered
2025-02-10
Start date
2025-01-24
Completion date
2025-02-25
Last updated
2026-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Brief summary

The aim of this study is to evaluate and compare the performance of two soft contact lenses.

Detailed description

The aim of this study is to evaluate and compare the performance of a hydrogel lens and a silicone hydrogel lens in existing myopic soft lens wearers.

Interventions

15 minutes of daily wear

15 minutes of daily wear

Sponsors

CooperVision, Inc.
Lead SponsorINDUSTRY
Centre for Ocular Research & Education, Canada
CollaboratorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Are at least 18 years of age and have full legal capacity to volunteer; 2. Have understood and signed an information consent letter; 3. Are willing and able to maintain the appointment schedule; 4. Are an adapted soft contact lens wearer; 5. Have a vertex-corrected contact lens prescription of -1.00DS to -6.00DS (inclusive) in each eye; 6. Have a refraction with a cylinder component of no more than -1.00DC in each eye; 7. Can be fitted with and achieve a distance visual acuity of +0.10 logMAR or better in each eye with the study contact lenses.

Exclusion criteria

1. Are participating in any concurrent clinical or research study; 2. Have any known active ocular disease and/or infection or slit lamp findings that would contraindicate contact lens use; 3. Have a systemic condition that would contraindicate contact lens use; 4. Are using any systemic or topical medications that would contraindicate contact lens use; 5. Have known sensitivity to the diagnostic fluorescein sodium to be used in the study; 6. Are an employee of the Centre for Ocular Research \& Education directly involved in the study (i.e. on the delegation log).

Design outcomes

Primary

MeasureTime frameDescription
Lens ComfortImmediately after lens applicationThe primary outcome of this study is lens comfort immediately after lens application on a scale of 0-100 (0= worst, 100=best).

Countries

Canada

Contacts

PRINCIPAL_INVESTIGATORLyndon Jones, PhD FCOptom

Centre for Ocular Research and Education

Participant flow

Pre-assignment details

Forty Five participants were screened. All the participants who were eligible in the study were included in the analysis. (n=45)

Baseline characteristics

Characteristic
Age, Continuous30.0 years
STANDARD_DEVIATION 10.8
Sex: Female, Male
Female
34 Participants
Sex: Female, Male
Male
11 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 450 / 45
other
Total, other adverse events
0 / 450 / 45
serious
Total, serious adverse events
0 / 450 / 45

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 1, 2026